| abstract |
The invention relates to CGRP antagonists of general formula (I), in which A, U, V, W, X and R<1> to R <3> are as defined in claim 1, the tautomers, diastereomers, enantiomers, hydrates, mixtures, salts, hydrates of the salts, in particular the physiologically-acceptable salts thereof with inorganic or organic acids, medicaments containing said compounds and the use and methods for production thereof. |